Skip to main content

Akebia Therapeutics dba Keryx Biopharmaceutials, Inc

Recalls

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20201
20211
Download CSV

FDA Recall Terminated Historical recordClass III

Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., 245 First Street, Suite 1400, Cambridge, MA 02142, USA, NDC 59922-0631-01.

by Akebia Therapeutics dba Keryx Biopharmaceutials, Inc

Reason
Failed Dissolution Specifications
Published
February 24, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., One Marina Park Drive, 12th Floor, Boston, MA 02210, NDC 59922-631-01

by Akebia Therapeutics dba Keryx Biopharmaceutials, Inc

Reason
CGMP Deviations
Published
December 30, 2020
Distribution
Nationwide

View recall →

Showing 1–2 of 2 results

This page lists recalls that name Akebia Therapeutics dba Keryx Biopharmaceutials, Inc as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.